Global clinical microbiology market to reach $6.9b by 2029

Market expansion is projected to record a 6.5% CAGR within the forecast period.

The global clinical microbiology market is expected to reach $6.9b in terms of revenue at a compound annual growth rate (CAGR) of 6.5% until 2029.

A report by MarketsandMarkets revealed that the market is driven by rising demand across various industries seeking quality assurance and regulatory compliance.

“Challenges in refining accurate analytical techniques create openings for service providers, while government efforts foster investment and creativity,” The report said.

Meanwhile, the instrument segment is projected to witness notable market share growth within the forecast period.

The segment’s expansion is driven by key factors such as extensive traditional laboratory instrument adoption, ongoing advancements in molecular techniques and proteomics, and a shift towards laboratory automation in clinical settings.